Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 61.55
+2.55 (4.32%)
Nov 20, 2025, 9:29 AM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 17.38 billion as of November 19, 2025. Its market cap has increased by 46.33% in one year.
Market Cap
17.38B
Enterprise Value
15.27B
Revenue
955.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
61.55
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has decreased from 18.43B to 17.38B, a decrease of -5.68%. That is a compound annual growth rate of -1.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 17.46B | 104.97% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | 18.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 323.98B |
| Hansoh Pharmaceutical Group Company | 236.23B |
| JD Health International | 222.18B |
| Innovent Biologics | 154.92B |
| WuXi Biologics | 130.87B |
| Sino Biopharmaceutical | 124.78B |
| Akeso | 107.04B |
| Sichuan Kelun-Biotech Biopharmaceutical | 101.44B |